Esomeprazole and omeprazole might enhance the serum concentrations of benzodiazepines (through CYP2C19 inhibition) resulting in elevated adverse effects like drowsiness, Even though the clinical relevance is very low in most clients – monitor the individual for adverse effects (e.The objective of this review was To judge the anxiolytic, sedative,

Esomeprazole and omeprazole may possibly raise the serum concentrations of benzodiazepines (by means of CYP2C19 inhibition) leading to greater adverse effects such as drowsiness, Even though the clinical relevance is small in the majority of patients – watch the affected person for adverse effects (e.The objective of this analyze was To guage the